187 views
Stock image by zinkevych

iX Biopharma upsizes placement to raise $6.7m

It will fund expanses from its US expansion and purchase of new equipment amongst others.

iX Biopharma Ltd has upsized its proposed placement to 67 million new shares, increasing its aggregate gross proceeds to $6.7m from the initial $5m target, the company said in a filing. 

The new shares represent about 7% of its enlarged share capital of 955.84 million.

The proceeds are expected to fund expenses in connection with the group's expansion into the US, purchase of equipment, general working capital and fees, and expenses incurred in the proposed placement of $300,000, and debt repayment. 

Institutional investors, including Lion Global Investors Limited (on behalf of its clients) and Ginko-AGT Global Growth Fund, subscribed to the placement. The shares were issued under the general mandate approved at the company’s 2025 annual general meeting.

iX Biopharma will seek approval for the listing and quotation of the new shares on the Singapore Exchange’s Catalist board through its sponsor, UOB Kay Hian Private Limited. The company confirmed that none of its directors or substantial shareholders participated in the placement.
 

Join Singapore Business Review community
A NOTE FROM SINGAPORE BUSINESS REVIEW

If you've been wondering whether SBR could work for your company — yes, probably.

A lot of the companies we partner with started as readers. They'd been following our coverage for a while, saw their own customers and competitors in it, and eventually asked the obvious question: could we do something with you? The answer is usually yes. The shape of it depends on what you're trying to do.


The options are broader than most people assume — thought leadership articles, sponsored content, industry summits across Southeast Asia, regional awards programmes, podcasts, and media placements in print and digital. Some partners use one channel; most use a mix. We figure out the right combination by starting with your brief, not with our rate card.


So if the question has been on your mind, here's the easy way to ask it.

We'll tell you honestly whether we can help, and how. It's a better use of everyone's time.